
| GRANTS INITIATED IN 2026 | |||
|---|---|---|---|
| Sl. No. | Name of the Project | Name of PI | Funding Agency |
| 1 | Translational Decoding of TCR-Neoantigen dynamicsin Oral Precancerous lesions progression towards frank cancer: Integrating spatial sequencing and AI for early prediction biomarker development | Dr. Nidhan K. Biswas | Indian Council of Medical Research |
| 2 | Advancing Pandemic preparedness: Innovative Multidisciplinary Strategies for COMBATing Severe | Prof. Arindam Maitra | Department of Biotechnology, India |
| 3 | Investigating the Crosstalk Between Lysine Hydroxylases and Matrix Metalloproteinases in Extracellular Matrix Remodelling and Chemoresistance in Pancreatic Cancer | Dr. Srikanta Goswami | Anusandhan National Research Foundation |
| 4 | Development of a chip to predict steroid responsiveness in children with idiopathic nephrotic syndrome: A global whole transcriptomics (lncRNA-miRNA-mRNA network) based approach | Dr. Kaushik Das | Anusandhan National Research Foundation |
| 5 | Genetically Engineered Macrophage Microvesicles Carrying Human β-Defensin-2 for Targeted Treatment of Uropathogenic E. coli in Diabetic Bladder Infections | Dr. Soumitra Mohanty | Anusandhan National Research Foundation |
| 6 | Investigating the role of Arid1a in chromatin organization: Potential translation to cancer therapy | Dr. Sriram Sridharan | Anusandhan National Research Foundation |
| 7 | Deciphering the role of hypoxia in regulating the cell cycle dynamics, migratory, and invasive abilities of breast | Prof. Arindam Maitra | Anusandhan National Research Foundation |
| GRANTS INITIATED IN 2025 | |||
| Sl. No. | Name of the Project | Name of PI | Funding Agency |
| 1 | MOMI India-Scale up and Nutritional analysis (Phase III) | Prof. Arindam Maitra | Biotechnology Industry Research Assistance Council |
| 2 | Identifying omic-based biomarkers for immunotherapy response in Indian oral cancer: A prospective study | Dr. Nidhan K. Biswas | Lady Tata Memorial Trust |
| 3 | Evaluation of spatial ecology of Tie2-activated myofibroblastic-CAFs as potential target against aggressive oral cancer | Prof. Sandeep Singh | Department of Biotechnology, India |
| 4 | Investigating the link between p53 P300S mutation and colon cancer development using Indian patient samples, cellular and animal model systems | Dr. Sagar Sengupta | Department of Biotechnology, India |
| 5 | Coagulation factor, activated factor X (FXa) promotes the release of extracellular vesicles from human metastatic colorectal cancer cells: Contribution to CRC pathogenesis | Dr. Kaushik Das | Anusandhan National Research Foundation |
| 6 | Genetic and Epigenetic drivers of chewing tobacco (Kaddipudi) habituated woman oral cancer patients | Prof. Arindam Maitra | Department of Biotechnology, India |
| 7 | Expansion of INSACOG – Wastewater Surveillance of SARS-CoV-2, Emerging Pathogens and Antimicrobial Resistance through Genomics-Based Methods | Project Coordinator: Prof. Arindam Maitra PI: Dr. Souvik Mukherjee | Biotechnology Industry Research Assistance Council |
| 8 | Mechanisms of replication fork stabilization | Dr. Sriram Sridharan | Department of Biotechnology, India |
| 9 | Identification of potentially aggressive CTCS (Circulating Tumor Cells) using single-cell multi-omics: Implications for prognostication and therapeutic target identification in Oral Squamous Cell Carcinoma patients | Prof. Arindam Maitra | Indian Council of Medical Research |
| GRANTS INITIATED IN 2024 | |||
| Sl. No. | Name of the Project | Name of PI | Funding Agency |
| 1 | Thrombin induces, in a concentration dependent, distinct population of extracellular vesicles from the endothelium: Its impact on homeostasis and cytoprotection | Dr. Kaushik Das | Department of Biotechnology, India |
| 2 | Study on the epigenetic mechanism of JAK-STAT driven plasticity in oral cancer stem cells for its therapeutic value | Dr. Sandeep Singh | Department of Biotechnology, India |
| 3 | Pylonephritis in Diabetics: Identifying underlying mechanisms influencing recurrent infection and establishing host mediated therapeutic approaches | Dr. Soumitra Mohanty | Department of Biotechnology, India |
| 4 | Investigating the Gut Microbiome and Host Epigenomic Profiles in Preterm Stunted Infants at 6 months of Age in a Low to Mid Socioeconomic Neighborhood of North India | Dr. Souvik Mukherjee | Anusandhan National Research Foundation |
| 5 | Understanding The Molecular Mechanism In Ceramide Induced Pathological Activation Of Nek7/Nlrp3 – Inflammasome | Dr. P.B. Raghavendra | Department of Biotechnology, India |
| 6 | Investigating the role of PTPRM gene in lens thickness, identified from quantitative trait genome-wide association study | Dr. Moulinath Acharya | Anusandhan National Research Foundation |
| 7 | Influence of host genomic alteration on atopic dermatitis and involvement of gut-skin metagenomic axis | Dr. Souvik Mukherjee | Department of Biotechnology, West Bengal |
| 8 | Developing Research support services at National Institute of Biomedical Genomics | Dr. Alpana Dave | DBT/Wellcome India Alliance |
| GRANTS INITIATED IN 2023 | |||
| Sl. No. | Name of the Project | Name of PI | Funding Agency |
| 1 | Whole Genome Sequencing of MTB Clinical Strains for Determining Drug Resistance and Strain lineage in India: A structured Nationwide approach | Prof. Arindam Maitra | Department of Biotechnology, India |
| 2 | MOMI: Biorepository Local Analysis India Phase II | Prof. Arindam Maitra | Biotechnology Industry Research Assistance Council |
| 3 | Identify, characterize and determine the in vivo efficacy of small molecules using a synthetic lethality screen which targets the major DNA repair pathways in colon and lung cancer | Dr. Sagar Sengupta | Indo-French Centre for the Promotion of Advanced Research/CEFIPRA |
| 4 | Proteomic profiling of extracellular vesicles (EVs) to identify markers that may facilitate specific isolation of tumor EVs from patient serum | Prof. Kartiki V. Desai | Indian Council of Medical Research |
| 5 | J.C. Bose Fellowship | Dr. Sagar Sengupta | Anusandhan National Research Foundation |
| 6 | Diabetes and Diabetic Retinopathy Microbiome Study - India | Dr. Souvik Mukherjee | Hyderabad Eye Research Foundation, LVPEI |
| 7 | Elucidating the role of systemic immune response in Metastasis using Single Cell RNA Sequencing: Relation with Circulating Tumor Cell Biology and Clinical Implications | Prof. Arindam Maitra | Anusandhan National Research Foundation |
| 8 | Validation of Circulating Tumour Cells (CTCs) based diagnostics in Prognosticating Oral Squamous Cell Carcinoma: An Approach to Personalized Cancer Management | Prof. Arindam Maitra | Indian Council of Medical Research |
| 9 | Fast detection of driver mutations and genes from cancer genomics data using an integrative machine learning-based approach | Dr. Nidhan K. Biswas | Indian Council of Medical Research |
| 10 | Determine the mechanism of the turnover of key mitochondrial helicase, RECQL4, inside the organelle | Dr. Sagar Sengupta | Council of Scientific and Industrial Research |
| GRANTS INITIATED IN 2022 | |||
| Sl. No. | Name of the Project | Name of PI | Funding Agency |
| 1 | Genomic surveillance of SARS-CoV-2 in India: Indian SARS-CoV-2 Genomics Consortium (INSACOG)-Phase II | Prof. Arindam Maitra (Sentinel), Dr. Souvik Mukherjee (Sewage) | Department of Biotechnology, India |
| 2 | Evaluation of growth factors and stem cell combination, novel formulation synergize to accelerate wound healing in diabetic foot ulcer models | Dr. P. B. Raghavendra | Chellaram Diabetes Research Centre |
| 3 | Design and Synthesis of Novel Carboline-Nucleosides with Potential Viral RdRp Inhibitor Activity: Development of Broad-Spectrum Antivirals Against RNA Viruses | Dr. Anup Mazumder | Science and Engineering Research Board |
| 4 | Interaction of Jumonji domain containing 6 protein (JMJD6) and Y-box containing protein 1 (YBX1) and its impact on breast cancer progression | Prof. Kartiki V. Desai | Science and Engineering Research Board - POWER |
| 5 | Investigating the molecular mechanism of action of 8q24.21 region specific long noncoding RNAs CASC19, CCAT1 in Pancreatic ductal adenocarcinoma | Dr. Srikanta Goswami | Department of Biotechnology, India |
| 6 | Investigating role of malignancy specific genes OSBPL3 and DLGAP5 in development and progression of pancreatic ductal adenocarcinoma | Dr. Srikanta Goswami | Science and Engineering Research Board |
| 7 | Deciphering the role of epigenetic modification in anti viral immune response to develop novel drug target | Dr. Anup Mazumder | Science and Engineering Research Board |